Warning letters, 483s, Recalls, Import Alerts, Audit observations
The European Medicines Agency (EMA) has initiated a review of finasteride and dutasteride due to
EMA(Europeans Medicines Agency) has updated the Appendix 1 Acceptable intakes established for N-nitrosamines with 15
Prospective applicants of Complex Generics (CG) can request for a joint meeting with FDA OGD
The GMP/GDP Inspectors Working Group coordinated by EMA has decided to continue the extension of
The European Commission has published the first Union list of critical medicines, together with the
EMA, the European Commission (EC) and the Heads of Medicines Agencies (HMA) are phasing out
